Note 3 - Divestitures

12 Months Ended

Dec. 31, 2015

Notes to Financial Statements

Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]

(3) Divestitures

On December 21, 2015, the Company completed the sale of selected assets and liabilities related to the clinical workflow product of the Predictive Analytics operating segment, for a net cash amount of approximately $1.6 million.  The Company recorded a gain of approximately $1.1 million from the sale, which is included in other income on the Statement of Income.  In connection with the closing of the transaction, $300,000 was placed in escrow until December 2016 to cover certain indemnification claims pursuant to the purchase agreement.  The Company will record an additional gain on the sale when and if any of the escrow amount is released.   The lack of operating results from this business due to its divestiture will not have a major effect on our operations and financial results, and, accordingly, it was not classified as a discontinued operation for any of the periods presented.  The following assets and liabilities were included in the sale:

Assets and Liabilities Sold
($ in thousands)
Assets:
Prepaid Expenses	$	3
Software and Technology		161
Other intangible assets		819
Goodwill		276
Liabilities:
Deferred Revenue		(748	)
Net assets sold	$	511